While the pro-death community continues to push embryonic stem cell research, even though it has yet to produce a single medical success, Scientific American points out yet another problem with this line of research.
Not only does it involve the destruction of human life, the human body tends to reject these sells as foreign (which they are) and produce cancerous tumors.
Researchers at Stanford University School of Medicine found that mice mounted an immune response after being injected with human embryonic stem cells (hESCs). The result: all the transplanted stem cells—which hold the promise of maturing into several different types of tissue—were dead within a week...The U.S. Food and Drug Administration, however, has not approved the injection of hESCs into patients because the raw cells have the potential to become cancerous.
The cells die off in a few days, and when more are injected to replace them, the next set die off even faster.
This is a natural response when anything is transplanted from one organism to another. I have a friend who received a kidney transplant some time back...and he will be on anti-rejection drugs the rest of his life to keep his body from rejecting the transplanted kidney.
Meanwhile, adult stem cell research has already produced dozens of successes ranging from new bone growth, diabetes treatment, regenerating heart tissue and treating leukemia.
There is no need to destroy human life in pursuit of a therapy that isn't producing anything and obviously faces major hurdles. Especially when there is a line of research that is already producing results without destroying human life.
HT to the FRC blog.
0 comments:
Post a Comment